切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2022, Vol. 11 ›› Issue (03) : 172 -175. doi: 10.3877/cma.j.issn.2095-3216.2022.03.011

综述

血液透析患者透析低血压的研究进展
杨洁1, 王红叶1, 张蕊1,()   
  1. 1. 150001 哈尔滨,哈尔滨医科大学附属第二医院肾内科
  • 收稿日期:2022-03-09 出版日期:2022-06-28
  • 通信作者: 张蕊

Research progress of intradialysis hypotension in hemodialysis patients

Jie Yang1, Hongye Wang1, Rui Zhang1,()   

  1. 1. Department of Nephrology, Second Hospital Affiliated to Harbin Medical University, Harbin 150001, Heilongjiang Province, China
  • Received:2022-03-09 Published:2022-06-28
  • Corresponding author: Rui Zhang
引用本文:

杨洁, 王红叶, 张蕊. 血液透析患者透析低血压的研究进展[J/OL]. 中华肾病研究电子杂志, 2022, 11(03): 172-175.

Jie Yang, Hongye Wang, Rui Zhang. Research progress of intradialysis hypotension in hemodialysis patients[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2022, 11(03): 172-175.

透析低血压(IDH)是维持性血液透析(MHD)的常见并发症之一,且发生率始终居高不下,影响患者的生活质量及长期预后。因此规避IDH风险十分必要。近年来,随着病理生理研究的不断深入,IDH优化防治方面的进展迅速,如生物反馈技术、低温透析、中医疗法等。本文围绕IDH定义、危害、病理生理、防治策略等最新进展进行综述,旨在为防治IDH提供资料和参考。

Intradialysis hypotension (IDH) is one of the common complications of maintenance hemodialysis (MHD), and its incidence remains high, affecting the quality of life and long-term prognosis of patients. Therefore, it is necessary to avoid IDH risks. In recent years, with the deepening of pathophysiological research, rapid progress has been made in the optimization of prevention and treatment of IDH, such as biofeedback technology, cold dialysis, and traditional Chinese medicine therapy. This article reviewed the latest progress in the definition, harm, pathophysiology, and prevention and treatment strategies of IDH, aiming to provide information and reference for the prevention and treatment of IDH.

图1 透析中低血压预防措施注:EBPG:欧洲最佳实践指南;IDH:透析低血压
[1]
Kuipers J, Verboom LM, Ipema KJR, et al. The prevalence of intradialytic hypotension in patients on conventional hemodialysis: a systematic review with meta-analysis [J]. Am J Nephrol, 2019, 49(6): 497-506.
[2]
Kooman J, Basci A, Pizzarelli F, et al. EBPG guideline on haemodynamic instability [J]. Nephrol Dial Transplant, 2007, 22(Suppl 2): ii22-ii44.
[3]
K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients [J]. Am J Kidney Dis, 2005, 45(4 Suppl 3): S1-S153.
[4]
Kim KY, Park HS, Kim JS, et al. Comparison of intradialytic blood pressure metrics as predictors of all-cause mortality [J]. Clin Kidney J, 2021, 14(12): 2600-2605.
[5]
Yu J, Liu Z, Shen B, et al. Intradialytic hypotension as an independent risk factor for long-term mortality in maintaining hemodialysis patients: a 5-year follow-up cohort study [J]. Blood Purif, 2018, 45(4): 320-326.
[6]
Chang TI, Paik J, Greene T, et al. Intradialytic hypotension and vascular access thrombosis [J]. J Am Soc Nephrol, 2011, 22(8): 1526-1533.
[7]
Mc Causland FR, Tumlin JA, Roy-Chaudhury P, et al. Intradialytic hypotension and cardiac arrhythmias in patients undergoing maintenance hemodialysis: results from the monitoring in dialysis study [J]. Clin J Am Soc Nephrol, 2020, 15(6): 805-812.
[8]
Cedeño S, Desco M, Aleman Y, et al. Intradialytic hypotension and relationship with cognitive function and brain morphometry [J]. Clin Kidney J, 2020, 14(4): 1156-1164.
[9]
Jansen MA, Hart AA, Korevaar JC, et al. Predictors of the rate of decline of residual renal function in incident dialysis patients [J]. Kidney Int, 2002, 62(3): 1046-1053.
[10]
Burton JO, Jefferies HJ, Selby NM, et al. Hemodialysis-induced cardiac injury: determinants and associated outcomes [J]. Clin J Am Soc Nephrol, 2009, 4(5): 914-920.
[11]
Yu J, Chen X, Li Y, et al. High ultrafiltration rate induced intradialytic hypotension is a predictor for cardiac remodeling: a 5-year cohort study [J]. Ren Fail, 2021, 43(1): 40-48.
[12]
Macedo E, Karl B, Lee E, et al. A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients [J]. Crit Care, 2021, 25(1): 18.
[13]
Mc Causland FR, Claggett B, Sabbisetti VS, et al. Hypertonic mannitol for the prevention of intradialytic hypotension: a randomized controlled trial [J]. Am J Kidney Dis, 2019, 74(4): 483-490.
[14]
Aronoff GR. The effect of treatment time, dialysis frequency, and ultrafiltration rate on intradialytic hypotension [J]. Semin Dial, 2017, 30(6): 489-491.
[15]
Ettema EM, Zittema D, Kuipers J, et al. Dialysis hypotension: a role for inadequate increase in arginine vasopressin levels? A systematic literature review and meta-analysis [J]. Am J Nephrol, 2014, 39(2): 100-109.
[16]
Marshall MR, Vandal AC, de Zoysa JR, et al. Effect of low-sodium versus conventional sodium dialysate on left ventricular mass in home and self-care satellite facility hemodialysis patients: a randomized clinical trial [J]. J Am Soc Nephrol, 2020, 31(5): 1078-1091.
[17]
Gabutti L, Bianchi G, Soldini D, et al. Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids [J]. Nephrol Dial Transplant, 2009, 24(3): 973-981.
[18]
Mustafa RA, Bdair F, Akl EA, et al. Effect of lowering the dialysate temperature in chronic hemodialysis: a systematic review and meta-analysis [J]. Clin J Am Soc Nephrol, 2016, 11(3): 442-457.
[19]
Yoowannakul S, Kotecha T, Fontana M, et al. Do pre-hemodialysis estimates of extracellular volume excess using bioimpedance and N-terminal brain natriuretic peptide correlate with cardiac chamber size measured by magnetic resonance imaging? [J]. Ther Apher Dial, 2019, 23(4): 362-368.
[20]
Jelicic I. Relationship of a food intake during hemodialysis and symptomatic intradialytic hypotension [J]. Hemodial Int, 2021, Epub ahead of print.
[21]
Kim TW, Chang TI, Kim TH, et al. Association of ultrafiltration rate with mortality in incident hemodialysis patients [J]. Nephron, 2018, 139(1): 13-22.
[22]
Leung KCW, Quinn RR, Ravani P, et al. Randomized crossover trial of blood volume monitoring-guided ultrafiltration biofeedback to reduce intradialytic hypotensive episodes with hemodialysis [J]. Clin J Am Soc Nephrol, 2017, 12(11): 1831-1840.
[23]
Dasgupta I, Thomas GN, Clarke J, et al. Associations between hemodialysis facility practices to manage fluid volume and intradialytic hypotension and patient outcomes [J]. Clin J Am Soc Nephrol, 2019, 14(3): 385-393.
[24]
Brunelli SM, Sibbel S, Do TP, et al. Facility dialysate calcium practices and clinical outcomes among patients receiving hemodialysis: a retrospective observational study [J]. Am J Kidney Dis, 2015, 66(4): 655-665.
[25]
Bullen A, Rifkin D, Trzebinska D. Individualized cool dialysate as an effective therapy for intradialytic hypotension and hemodialysis patients′ perception [J]. Ther Apher Dial, 2019, 23(2): 145-152.
[26]
Maheshwari V, Lau T, Samavedham L, et al. Effect of cool vs warm dialysate on toxin removal: rationale and study design [J]. BMC Nephrol, 2015, 16: 25.
[27]
Locatelli F, Altieri P, Andrulli S, et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD [J]. J Am Soc Nephrol, 2010, 21(10): 1798-1807.
[28]
林玲,彭梅,罗凯,等. 参麦注射液对血液透析相关性低血压患者血压、血清白蛋白及透析充分性的影响[J]. 河北中医2019, 41(5): 706-709.
[29]
于晓瑜,陆丹. 针灸并用预防血液透析相关性低血压的疗效观察[J]. 中国中西医结合肾病杂志2018, 19(4): 347-348.
[30]
Rhee SY, Song JK, Hong SC, et al. Intradialytic exercise improves physical function and reduces intradialytic hypotension and depression in hemodialysis patients [J]. Korean J Intern Med, 2019, 34(3): 588-598.
[31]
Frankenfield DL, Weinhandl ED, Powers CA, et al. Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D [J]. Am J Kidney Dis, 2012, 59(5): 670-681.
[32]
Roberts MA, Pilmore HL, Ierino FL, et al. The β-blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trial [J]. Am J Kidney Dis, 2016, 67(6): 902-911.
[33]
Assimon MM, Brookhart MA, Fine JP, et al. A comparative study of carvedilol versus metoprolol initiation and 1-year mortality among individuals receiving maintenance hemodialysis [J]. Am J Kidney Dis, 2018, 72(3): 337-348.
[34]
Brunelli SM, Cohen DE, Marlowe G, et al. The impact of midodrine on outcomes in patients with intradialytic hypotension [J]. Am J Nephrol, 2018, 48(5): 381-388.
[35]
Razeghi E, Dashti-Khavidaki S, Nassiri S, et al. A randomized crossover clinical trial of sertraline for intradialytic hypotension [J]. Iran J Kidney Dis, 2015, 9(4): 323-330.
[36]
Imai E, Fujii M, Kohno Y, et al. Adenosine A1 receptor antagonist improves intradialytic hypotension [J]. Kidney Int, 2006, 69(5): 877-883.
[1] 唐博, 罗季平, 周桃, 黄多, 刘廷琼, 陈亚萍, 岳文胜. 慢性肾衰竭血液透析患者造瘘侧上肢肱动脉-指端微小动脉血流动力学变化特点分析[J/OL]. 中华医学超声杂志(电子版), 2023, 20(12): 1276-1281.
[2] 杜军霞, 赵小淋, 王浩然, 高志远, 王曼茜, 万楠熙, 张冬, 丁潇楠, 任琴琴, 段颖洁, 汤力, 朱晗玉. 2 型糖尿病的血液透析患者肠道微生物组学高通量测序分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 313-320.
[3] 张少青, 吕玉风, 董海霞. 中性粒细胞百分比/白蛋白比值对维持性血液透析患者全因死亡的预测作用[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 321-326.
[4] 周敏, 徐阳, 胡莹, 黄先凤. 维持性血液透析患者血清β-CTX、N-MID 和PICP 与冠状动脉钙化的关系及其诊断价值[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 256-260.
[5] 苏朝江, 刘佳丽, 姜燕, 许厅, 刘俪婷, 陈彦, 刘宗旸. 血透患者小直径动脉经皮腔内血管成形术后行动静脉内瘘术的疗效[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 249-255.
[6] 马丽洁, 赵素梅, 孙芳, 孙倩美. 平均血小板体积和平均血小板体积/血小板计数比值对血液透析患者血管通路失功的潜在预测价值[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 61-67.
[7] 唐全兴, 周畅. 维持性血液透析患者血清suPAR对动静脉内瘘狭窄发生的诊断价值[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 74-78.
[8] 冯娟, 詹伟强. 维持性血液透析患者血清热休克蛋白70及簇集蛋白水平与主要不良心血管事件的相关性[J/OL]. 中华肾病研究电子杂志, 2024, 13(01): 34-38.
[9] 兰洁, 薛福平, 任娇娇, 廖智菲, 焦原野, 李静, 王利华. 维持性血液透析患者的住院情况及其影响因素分析[J/OL]. 中华肾病研究电子杂志, 2023, 12(06): 301-307.
[10] 刘键, 张晓娜, 徐宏娟, 彭丽敏, 宋晶晶. 环硅酸锆钠对血液透析患者营养状态的影响:前瞻性巢式病例对照研究[J/OL]. 中华肾病研究电子杂志, 2023, 12(06): 308-313.
[11] 许厅, 熊智倩, 刘俪婷, 姜燕, 苏朝江, 刘宗旸. 维持性血液透析患者皮肤瘙痒症的发病机制及治疗研究进展[J/OL]. 中华肾病研究电子杂志, 2023, 12(06): 334-338.
[12] 赵伟, 李晓帆, 赵海丹. 维持性血液透析患者血尿酸等代谢指标的纵向数据分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(10): 1064-1070.
[13] 蒲蕾, 冯韵霖, 洪大情, 何强, 李贵森, 陈瑾. 蛋白质-能量消耗对血液透析患者预后的影响[J/OL]. 中华临床医师杂志(电子版), 2023, 17(10): 1051-1057.
[14] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
[15] 张祉昱, 裴月红, 于玲, 王军, 傅瑜. 偏头痛前驱症状临床表型及其病理生理机制探讨[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(01): 64-70.
阅读次数
全文


摘要